|
|||||
|
|
| Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut,exerts a systemic immune effect and alleviates Crohn’s disease with low rate of side effects: results of double blind Phase II clinical trial | |
| 摘 要： | |
| 收稿时间： | 2015 Feb 22 |